• Aucun résultat trouvé

IZABELA JELOVAC – SHORT CV

N/A
N/A
Protected

Academic year: 2022

Partager "IZABELA JELOVAC – SHORT CV"

Copied!
5
0
0

Texte intégral

(1)

IZABELA JELOVAC – SHORT CV

January, 2020

CONTACT

GATE Lyon-St Etienne. 93, chemin des Mouilles. 69130 Ecully. France izabela.jelovac[at]cnrs.fr

https://www.gate.cnrs.fr/spip.php?article21

https://scholar.google.es/citations?user=Mu2c6ngAAAAJ&hl=fr

ACADEMIC POSITIONS

Research professor (DR2) at CNRS since 2018, GATE Lyon-St Etienne.

Affiliated researcher, Hospinnomics (AP-HP and PSE), since 2017.

Researcher (CR1) at CNRS, GATE Lyon-St Etienne, 2009-2018.

Associate professor, Université de Liège, 2004-2009.

Assistant professor, Maastricht University, 2000-2004.

Assistant professor, Universidad de Vigo, Spain, 1998-2000.

Research and teaching fellow, Universidad Autonoma de Barcelona, 1993-1998.

EDUCATION

Habilitation (HDR), University of Lyon 2, 2007.

Ph.D. in Economics, Universidad Autonoma de Barcelona, 1998 (Summa cum laude).

RESEARCH INTERESTS

Health economics, industrial organization, incentives and contract theory, public economics.

GRANTS, HONORS AND SCHOLARSHIPS

CNRS Recruitment Campaign 2018; Ranked 4th.

CNRS Recruitment Campaign 2009; Ranked 1st.

Research grants as project leader from Chaire Santé (5 000 €) in 2011; from Chaire Santé (5 000 €) in 2010; from IReSP (145 000 €) in 2008-2010; from the Belgian National Bank (15 000 €) in 2005- 2007.

Research scholarship from the Spanish Ministry of Foreign Affairs, 1997.

ACADEMIC VISITS

University of Delaware, July-August, 2014.; HEC Lausanne, April, 2011; HEC Montreal, May, 2005;

Boston University, November, 2003 – March, 2004; Australian National University, July – August, 2002; Autonomous University of Barcelona, January – February, 2001.

(2)

PUBLICATIONS

REFEREED PUBLICATIONS

1. I. Jelovac, S. Kembou Nzale (2020). Regulation and altruism. Journal of Public Economic Theory 22(1), 49-68.

2. N. Houy, I. Jelovac (2019). Comparing approval procedures for new drugs. The World Economy 42(5), 1598-1619.

3. I. Jelovac, P. Polomé (2017). Incentives to patients versus incentives to health care providers: The users’ perspective. Health Economics 26 (12), e319-e331.

4. N. Houy, I. Jelovac (2015). Drug launch timing and international reference pricing. Health Economics 24 (8), 978-989.

5. I. Jelovac (2015). Physicians’ balance billing, supplementary insurance and access to health care.

International Journal of Health Economics and Management 15 (2), 269-280 (Formerly International Journal of Health Care Finance and Economics).

6. I. Jelovac (2015). On the relationship between the negotiated price of pharmaceuticals and the patients’ co-payment. Economics Bulletin 15 (1), 481-493.

7. I. Jelovac, F. Vandeninden (2014). How should donors give foreign aid? A theoretical comparison of aid modalities. European Journal of Development Research 26, 886-904.

8. M. Allard, I. Jelovac, P.T. Léger (2014). Payment mechanism and GP self-selection: Capitation versus fee for service. International Journal of Health Care Finance and Economics 14 (2), 143-160.

9. I. Jelovac (2014). Primary Care, Gatekeeping and Incentives. In: Anthony J. Culyer (ed.), Encyclopedia of Health Economics, Vol 3. San Diego: Elsevier. pp. 142-145.

10. M. Allard, I. Jelovac, P.T. Léger (2011). Treatment and referral decisions under different physician payment mechanisms. Journal of Health Economics 30 (5), 880-893.

11. B. Garcia-Mariñoso, I. Jelovac, P. Olivella (2011). External referencing and pharmaceutical price negotiation. Health Economics 20 (6), 737-756.

12. K. Habbani, I. Jelovac, W. Groot (2007). Do free of charge public health services impede the cost recovery policies in Khartoum state of Sudan? Eastern Mediterranean Health Journal 13 (4), 939- 952.

13. K. Habbani, I. Jelovac, W. Groot (2006). Household health-seeking behaviour in Khartoum, Sudan:

the willingness to pay for public health services if these services are of good quality. Health Policy 75, 140-158.

14. I. Jelovac, C. Bordoy (2005). Pricing and welfare implications of parallel imports in the

pharmaceutical industry. International Journal of Health Care Finance and Economics. 5 (1), 5-21.

15. B. Garcia-Mariñoso, I. Jelovac (2003) GP’s payment contracts and their referral practice. Journal of Health Economics 22 (4), 617-635.

16. I. Jelovac, I. Macho-Stadler (2002). Comparing organizational structures in health services. Journal of Economic Behavior and Organization. 49 (4), 501-522.

17. I. Jelovac (2001). Physicians’ payment contracts, treatment decisions and diagnosis accuracy.

Health Economics 10 (1), 9-25.

(3)

NON-REFEREED PUBLICATIONS

18. C. Franc, I. Jelovac (2018). Des “Nobels” de sciences économiques au service des systèmes de santé.

médecine/sciences 3 (34).

19. I. Jelovac (2014). Faire évoluer la rémunération des médecins pour mieux contrôler les dépenses médicales ? Dossier spécial : Santé. GATE Magazine 02.

20. P.P. Barros, B. Garcia-Mariñoso, I. Jelovac, X. Martinez-Giralt, P. Olivella (2006). Competition in Health Provision and Insurance. Madrid, Fundacion BBVA.

WORKING PAPERS - WORK IN PROGRESS

21. F. Barigozzi, I. Jelovac. Research funding and price negotiation for new drugs. WP 1902, GATE Lyon St Etienne.

22. I. Jelovac, M. Lefebvre. Informal care and caregivers occupation.

23. I. Jelovac, B. Rey-Fournier. Primary prevention, secondary prevention and decision thresholds.

24. E. Dargaud, I. Jelovac. Payment schemes for distance medicine.

25. R. Ellis, I. Jelovac. Provider Agency, Health Care Innovation, Pricing and Regulations.

26. D. Bardey, I. Jelovac. Quality, price and copayments.

27. I. Jelovac. Centralization versus decentralization: Further determinants.

28. I. Jelovac. Welfare effects of discrimination with subsidized goods.

TEACHING

Director, Msc Program “Economics and Finance”: University of Lyon, since 2017.

Health Economics: University of Lyon, since 2017; Maastricht University 2001 – 2004.

Industrial Organization: University of Lyon, since 2008; University of Delaware 2014; University of Liege 2003 – 2007; Autonomous University of Barcelona 1998.

Microeconomics: EMLyon 2010; University of Lyon 2007; Maastricht University 2001 – 2004;

University of Vigo 2000.

Game Theory: HEC-University of Liege 2004 – 2007.

Insurance and Financial Economics: Maastricht University 2001 – 2004.

Information Economics: University of Vigo 1998 – 2000.

Macroeconomics: University of Vigo 1999 – 2000.

(4)

SCIENTIFIC COMMITTEES

PH.D. SUPERVISION

S. Kembou Nzale, PhD 2019 Aix-Marseille School of Economics (with B. Ventelou); IPA since 2017.

L.F. Andrade, PhD 2013 University of Lyon 2 (with M. Grignon); Chaire ESSEC Santé since 2015.

F. Vandeninden, PhD 2011 Maastricht University (with P. Pestieau); World Bank since 2012.

PH.D. COMMITTEES

Audrey Boichard, Université d’Avignon, December 2019

Samuel Kembou Nzale, Aix-Marseille School of Economics, October 2019

Sébastien Parenty, Université de Grenoble-Alpes, 2018.

Julien Flaig, University of Lyon 2, 2018.

J.A. Rodríguez-Camacho, Universidad Autonoma de Barcelona, 2016.

J. Aka N’Dri, Université Mendes France, 2014.

B. Garcia Lorenzo, University of las Palmas de Gran Canarias, 2014.

Yaping Wu, Toulouse School of Economics, 2014.

G. Pelayo, Zaragoza Logistics Center, 2014.

L.F. Andrade, University of Lyon 2, 2013.

Li Zhang, University of Oslo, 2013.

J. Ing, University of Lyon 2, 2012.

F. Vandeninden, Maastricht University, 2011.

Y. Videau, University of Méditerranée Aix-Marseille II, 2010.

J. Civet, University of Franche-Comté, 2009.

E. Bonsang, University of Liege, 2008.

E. Verpillot, University of Franche-Comté, 2007.

M. Ekbladh, Lund University, 2007.

M.A. Razgallah, University of Lyon 2, 2007.

E. Paul, University of Liege, 2006.

K. Habbani, Maastricht University, 2004.

Habilitation (HDR) COMMITTEE

Bruno Versaevel, ENS Lyon, Juin 2018

(5)

CONFERENCE SCIENTIFIC COMMITTEES

European Health Economics Workshop (2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020).

World Congress on Health Economics (2009, 2011).

Meeting of AFSE (Association Française de Science Economique, 2011, 2014, 2017, 2018).

Meeting of ADRES (Association pour le développement de la Recherche en Economie et en Statistique, 2017, 2018, 2019, 2020).

CONFERENCE AND SEMINAR ORGANIZATION

Meeting of ADRES (GATE Lyon-St Etienne, February 2020).

In charge of the External Research Seminars (GATE Lyon-St Etienne, since 2009).

14th European Health Economics Workshop (GATE Lyon-St Etienne - May, 2013).

Des solutions pour accroître la productivité dans le secteur public : l'exemple des services de soins de santé (HEC Montréal - October, 2011).

Journée Maurice Marchand des Doctorants en Economie de la Santé (Lyon - November, 2007).

6th European Health Economics Workshop (University of Liège - June, 2005).

Workshop on Industrial Organization (University of Vigo - July, 1999).

SCIENTIFIC EVALUATIONS

Expert for ANR (Agence Nationale de la Recherche, France); Ministère des Solidarités et de la Santé (France); University of Verona (Italy); Ecole Centrale Lyon (France); Social Science and Humanities Research Council (Canada); Agencia Nacional de Evaluación y Prospectiva (Ministry of Education and Sciences, Spain); Agència per a la Qualitat del Sistema Universitari de Catalunya (Spain).

Reviewer for Annals of Public and Cooperative Economics, B.E. Journals in Economic Analysis &

Policy, Canadian Journal of Economics, Contemporary Economic Policy, Economica, Economic Inquiry, Economic Letters, European Economic Review, European Journal of Health Economics, Health Economics, Health Economics Review, Inquiry, International Journal of Health Care Finance and Economics, International Journal of Industrial Organization, Journal of Economic Behavior &

Organization, Journal of Economics & Management Strategy, Journal of the European Economic Association, Journal of Health Economics, Journal of Public Economic Theory, Journal of Public Economics, Portuguese Economic Journal, Regional Science and Urban Economics, Review of Industrial Organization, Revue d’Economie Politique, Revue Economique, Revue Française d’Economie, Scandinavian Journal of Economics, and Social Science and Medecine.

COLLECTIVE RESPONSIBILITIES

Elected member of the GATE Lyon St Etienne council, since 2009.

Nominated member of the Doctoral School, Université de Grenoble-Alpes, since 2018.

Coordinator of the pharmaceutical economics research group, Hospinnomics, since 2017.

Coordinator of the health economics research group, GATE Lyon St Etienne, 2008 – 2009.

Nominated member of the Research Commission at HEC-University of Liege, 2004 – 2007.

Références

Documents relatifs

DW sequence allowed the detection of 14 supplementary malignant lesions (20%) in comparison with standard MRI protocol. Moreover, this technique has been shown to be the most

Figure V shows a gradual secular decline of the share of capital income (again excluding capital gains realiza- tions) and dividends in the top 0.5 percent fractile from the 1920s

Modal pushover procedures for se1smic evaluation of reinforced concrete structures: using new nonlinear single degree of freedom systems L. Brun

Dilation behaviour of lÎme mortars for restoration work: application to the compatibility of cracked stone

Simulations of wave conditions on an open beach configuration: wind resolution, seaward forcing and whitecapping effects. M.I

Characterization and Attenuation of Sandwiched Deadband Pre Using Describing Function Analysis and Application to Electrohydraulic Systems Controlled by Closed-Center Valves.. Song

Model-Independent Control of a Flexible-Joint Robot Manipulatc Withit Chatlatanagulchai and Peter

Among a few known positive Turán densities, the triple graphs F 5 and F 3 , 2 are the only two of order five.. More precisely, we obtain the